These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3972798)

  • 1. Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74.
    Gerard C; Showell HJ; Hoeprich PD; Hugli TE; Stimler NP
    J Biol Chem; 1985 Mar; 260(5):2613-6. PubMed ID: 3972798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
    Stimler NP; Bach MK; Bloor CM; Hugli TE
    J Immunol; 1982 May; 128(5):2247-52. PubMed ID: 6174625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J; Damerau B; Vogt W
    Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and partial amino acid sequence of classical anaphylatoxin from pig serum: identification with Des-Arg-C5a.
    Zimmermann B; Damerau B; Vogt W
    Hoppe Seylers Z Physiol Chem; 1980; 361(6):915-24. PubMed ID: 7399411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The active site of human C4a anaphylatoxin.
    Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
    Abdullah NA; Assem ES; Damerau B
    Agents Actions; 1988 Apr; 23(3-4):181-4. PubMed ID: 2455983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino-acid sequence and disulfide linkages of the anaphylatoxin, des-Arg omega-C5a, from porcine serum.
    Zimmermann B; Vogt W
    Hoppe Seylers Z Physiol Chem; 1984 Feb; 365(2):151-8. PubMed ID: 6714942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes.
    Damerau B; Grünefeld E; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):181-4. PubMed ID: 732894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of immune complex-induced aggregation of polymorphonuclear neutrophils. I. C5a anaphylatoxin, neutrophil cationic proteins and their cleavage fragments.
    Camussi G; Tetta C; Bussolino F; Cappio FC; Coda R; Masera C; Segoloni G
    Int Arch Allergy Appl Immunol; 1980; 62(1):1-15. PubMed ID: 7372359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid sequence of guinea pig C3a anaphylatoxin.
    Gerard NP; Lively MO; Gerard C
    Protein Seq Data Anal; 1988; 1(6):473-8. PubMed ID: 3064079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
    Fernandez HN; Hugli TE
    J Biol Chem; 1978 Oct; 253(19):6955-64. PubMed ID: 690134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization.
    Gerard C; Hugli TE
    J Biol Chem; 1979 Jul; 254(14):6346-51. PubMed ID: 447720
    [No Abstract]   [Full Text] [Related]  

  • 15. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD; Chenoweth DE; Goldstein IM
    J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
    Stimler-Gerard NP
    Complement; 1986; 3(3):137-51. PubMed ID: 3026723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
    Scola AM; Higginbottom A; Partridge LJ; Reid RC; Woodruff T; Taylor SM; Fairlie DP; Monk PN
    J Biol Chem; 2007 Feb; 282(6):3664-71. PubMed ID: 17158873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologically active complement (C5)-derived peptides and their relevance to disease.
    Perez HD
    Crit Rev Oncol Hematol; 1984; 1(3):199-225. PubMed ID: 6241542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.
    Cui L; Carney DF; Hugli TE
    Protein Sci; 1994 Aug; 3(8):1169-77. PubMed ID: 7987212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.